Nasdaq1mon
Glucotrack, Inc. Achieves ISO 13485:2016 Certification, Enhancing Commitment to Quality in Diabetes Technology
(“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...
Mena FN1mon
Glucotrack Announces Successful Completion Of Its First Human Clinical Study Of Continuous Blood Glucose Monitor
About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently ...
Nasdaq1mon
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently ...